These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8718601)

  • 21. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
    Allemandi DA; Alovero FL; Manzo RH
    J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?
    Falcone M; Giannella M; Raponi G; Mancini C; Venditti M
    Clin Microbiol Infect; 2006 Jan; 12(1):96-7. PubMed ID: 16460556
    [No Abstract]   [Full Text] [Related]  

  • 25. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R; Cagni AE; Segú C
    Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
    Uete T; Matsuo K; Uete G
    Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in bacterial resistance to fluoroquinolones.
    Acar JF; Goldstein FW
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S67-73. PubMed ID: 8994781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada.
    LeBlanc L; Pépin J; Toulouse K; Ouellette MF; Coulombe MA; Corriveau MP; Alary ME
    Emerg Infect Dis; 2006 Sep; 12(9):1398-405. PubMed ID: 17073089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD
    S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract]   [Full Text] [Related]  

  • 30. Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
    Antony SJ; Bitter KM; Moreland T; Raudales F; Diaz-Luna H
    Clin Infect Dis; 1999 Nov; 29(5):1341-2. PubMed ID: 10524997
    [No Abstract]   [Full Text] [Related]  

  • 31. SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci.
    Kitzis MD; Goldstein FW; Ishida N; Acar JF
    J Antimicrob Chemother; 1995 Jul; 36(1):209-13. PubMed ID: 8537267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
    J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of quinolone resistance genes in a clinical isolate of quinolone-resistant MRSA.
    Kojima T; Yamagishi J; Oyamada Y; Yoshida H; Hattori H; Inoue M; Nakamura S
    Drugs; 1995; 49 Suppl 2():182-4. PubMed ID: 8549296
    [No Abstract]   [Full Text] [Related]  

  • 34. Quinolones in perspective.
    Neu HC
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():1-6. PubMed ID: 2258336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-level resistance to fluoroquinolones among Salmonella and Shigella.
    Willke A
    Clin Microbiol Infect; 2000 Dec; 6(12):687. PubMed ID: 11284932
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of action and resistance to fluoroquinolones].
    Alarcón T; López-Brea M
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):111-7. PubMed ID: 8714159
    [No Abstract]   [Full Text] [Related]  

  • 37. Lomefloxacin disc susceptibility criteria--a reappraisal.
    Smith JM; Hashmi ZS
    J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoroquinolone resistance in staphylococci: new challenges.
    Sanders CC; Sanders WE; Thomson KS
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S6-11. PubMed ID: 7729471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserving the effectiveness of antibiotics.
    Gaynes RP
    JAMA; 2010 Jun; 303(22):2293-4. PubMed ID: 20530785
    [No Abstract]   [Full Text] [Related]  

  • 40. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.